Detalhe da pesquisa
1.
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity.
Cancer Immunol Immunother
; 70(4): 1101-1113, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123754
2.
Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation.
Cell Rep
; 26(2): 469-482.e5, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625329
3.
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.
J Med Chem
; 59(4): 1440-54, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26061247
4.
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.
Cancer Discov
; 6(1): 80-95, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26701088
5.
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Cancer Discov
; 6(2): 202-16, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26645196
6.
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.
Cancer Res
; 75(18): 3865-3878, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26139243
7.
Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery.
Epigenetics Chromatin
; 8: 37, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26396593